$1.04
Today
as of Jul 22, 16:40 ET
Last 30 days
Recent Press Releases & News
VolitionRx (VNRX) Stock Gets Fair Value Boost As Analysts Split On Nu.Q Execution
VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
VolitionRx Announces Collaboration with Sysmex
Overview
52-week range
$1.75
$19
0% of range
Avg surprise (last 3)
-12.4%
Avg reaction (last 2)
-5.5%
0% positive
Latest IV / EM
1143%
EM ±265.8% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.82 | $-0.70 | -17.1% | -1,267% | -6.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.05 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.06 | $-0.05 | -20.0% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.06 | $-0.06 | 0.0% | — | -4.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.10 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.70 | -$1.20 | +41.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $985,076 | — | $627,277 | $406,688 | $246,385 | — | $474,522 | $395,797 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | — | $-5M | $-6M | $-6M | — | $-6M | $-7M |
| Net income | $-7M | — | $-5M | $-6M | $-5M | — | $-6M | $-7M |
| EPS (diluted) | $-0.97 | — | $-0.05 | $-0.06 | $-1.12 | — | $-0.07 | $-0.08 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $200,000 | $2M | $3M | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $5M | $2M | $1M | $3M | $3M | $4M | $7M | $7M |
| Total assets | $9M | $7M | $6M | $9M | $9M | $9M | $13M | $13M |
| Long-term debt | $6M | $6M | $6M | $6M | $6M | $4M | $4M | $4M |
| Total liabilities | $42M | $42M | $42M | $42M | $38M | $36M | $35M | $36M |
| Total equity | $-32M | $-34M | $-35M | $-32M | $-28M | $-25M | $-22M | $-22M |